Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Get Free Report) was the target of a significant drop in short interest in October. As of October 30th, there was short interest totaling 23,659 shares, a drop of 64.2% from the October 15th total of 66,171 shares. Based on an average daily trading volume, of 52,754 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.2% of the shares of the company are sold short.
Institutional Trading of Columbia Research Enhanced Value ETF
Several institutional investors have recently bought and sold shares of REVS. Essex Financial Services Inc. bought a new stake in shares of Columbia Research Enhanced Value ETF in the 3rd quarter worth about $2,335,000. Harbour Investments Inc. acquired a new stake in shares of Columbia Research Enhanced Value ETF in the third quarter valued at approximately $86,000. Inscription Capital LLC raised its position in Columbia Research Enhanced Value ETF by 43.3% in the 3rd quarter. Inscription Capital LLC now owns 56,081 shares of the company’s stock worth $1,840,000 after purchasing an additional 16,945 shares during the last quarter. Commonwealth Equity Services LLC bought a new stake in shares of Columbia Research Enhanced Value ETF during the third quarter worth $2,309,000. Finally, First Interstate Bank bought a new stake in shares of Columbia Research Enhanced Value ETF during the 3rd quarter valued at $3,602,000.
Columbia Research Enhanced Value ETF Price Performance
Shares of REVS traded down $0.25 on Monday, reaching $34.49. 34,346 shares of the stock traded hands, compared to its average volume of 50,081. The firm has a market cap of $403.53 million, a price-to-earnings ratio of 18.11 and a beta of 0.79. The stock’s 50-day moving average price is $33.84 and its 200-day moving average price is $31.82. Columbia Research Enhanced Value ETF has a 12 month low of $27.24 and a 12 month high of $35.44.
About Columbia Research Enhanced Value ETF
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
See Also
- Five stocks we like better than Columbia Research Enhanced Value ETF
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
